Lysine
Product Forms
Dose Distribution
Top Brands
Claims on Labels
Common Co-Ingredients
Top-Rated Lysine Products
Evidence Summary
L-Lysine analogues are researched for use as antifibrinolytics to prevent bleeding in individuals with haematological disorders. The research focuses on their potential to mitigate severe or life-threatening bleeding risks associated with thrombocytopenia.
Evidence by Condition
Lysine analogues are studied for their ability to prevent severe or life-threatening bleeding in patients with reduced platelet counts.
Effective Doses
Not specified in the provided research.
Key Findings
- Lysine analogues are used as antifibrinolytics for the prevention of bleeding in people with haematological disorders (PMID: 41670018)
- Lysine analogues are evaluated for preventing bleeding in patients with thrombocytopenia (PMID: 26978005)
- Research examines the use of lysine analogues to prevent life-threatening bleeding in haematological patients (PMID: 23897323)
Limitations
The provided research specifically addresses lysine analogues as antifibrinolytics rather than general L-Lysine nutritional supplementation.
Safety & Interactions
No safety information or contraindications were provided in the source text.
AI-generated summary from 3 peer-reviewed studies. Not medical advice. Always consult a healthcare provider.
Claims vs. Evidence
| Claim Type | % of Products | Evidence Required | Status |
|---|---|---|---|
| All Other | 100% | Tier D (Unclassified) | ✅ Supported |
| Structure/Function | 90% | Tier C (DSHEA Structure/Function (no pre-approval)) | ⚠️ Unsupported |
| Nutrient | 73% | Tier D (Unknown) | ✅ Supported |
Research by Topic
Research Evidence (3)
RATIONALE: People with haematological disorders are frequently at risk of severe or life-threatening bleeding as a result of thrombocytopenia (reduced platelet count). This is despite the routine use of prophylactic platelet transfusions to prevent b...
BACKGROUND: People with haematological disorders are frequently at risk of severe or life-threatening bleeding as a result of thrombocytopenia (reduced platelet count). This is despite the routine use of prophylactic platelet transfusions to prevent ...
BACKGROUND: Patients with haematological disorders are frequently at risk of severe or life-threatening bleeding as a result of thrombocytopenia. This is despite the routine use of prophylactic platelet transfusions (PlTx) to prevent bleeding once th...
Frequently Asked Questions
What is L-Lysine and what is it used for?
L-Lysine analogues are studied for use as antifibrinolytics to help prevent bleeding. They are primarily researched for their potential to reduce bleeding risks in individuals with haematological disorders.
Does L-Lysine help with low platelet counts?
There is moderate evidence that L-Lysine analogues may help prevent severe or life-threatening bleeding in patients with thrombocytopenia, which is a reduced platelet count. The research focuses on their ability to mitigate bleeding risks in haematological patients.
What is the effective dose of L-Lysine for preventing bleeding?
The provided research does not specify an effective dose for L-Lysine analogues. You should consult a healthcare professional for appropriate dosage instructions.
Are there any safety concerns or side effects with L-Lysine?
There is currently no specific safety information or contraindications provided in the available research. It is important to speak with a doctor to understand any potential risks before starting this supplement.
Does L-Lysine interact with other drugs?
There are no documented drug interactions for L-Lysine in the provided research. However, you should always discuss all supplements with your physician to prevent potential complications.
Who should avoid taking L-Lysine analogues?
The current research does not identify specific populations that should avoid L-Lysine analogues. Because safety data is limited, individuals with underlying health conditions should consult a medical professional first.
Can L-Lysine prevent life-threatening bleeding?
There is moderate evidence that L-Lysine analogues are being evaluated for their ability to prevent severe or life-threatening bleeding in patients with haematological disorders. The research specifically looks at their use in managing risks associated with thrombocytopenia.
Answers generated from research evidence. Not medical advice.